Private Advisor Group’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-3,912
Closed -$235K 2066
2023
Q1
$235K Buy
+3,912
New +$313K ﹤0.01% 1702
2022
Q4
Sell
-4,373
Closed -$332K 1874
2022
Q3
$332K Sell
4,373
-30
-0.7% -$2.34K ﹤0.01% 1424
2022
Q2
$306K Sell
4,403
-362
-8% -$27.3K ﹤0.01% 1636
2022
Q1
$395K Sell
4,765
-942
-17% -$69.4K ﹤0.01% 1537
2021
Q4
$428K Sell
5,707
-474
-8% -$47.6K ﹤0.01% 1532
2021
Q3
$718K Buy
6,181
+417
+7% +$63K ﹤0.01% 1345
2021
Q2
$1.28M Sell
5,764
-663
-10% -$129K 0.01% 935
2021
Q1
$850K Sell
6,427
-320
-5% -$50.6K 0.01% 1072
2020
Q4
$1.17M Sell
6,747
-265
-4% -$36.3K 0.01% 841
2020
Q3
$781K Buy
7,012
+55
+0.8% +$4.4K 0.01% 882
2020
Q2
$413K Sell
6,957
-98
-1% -$6.45K 0.01% 1090
2020
Q1
$475K Buy
7,055
+1,510
+27% +$119K 0.01% 913
2019
Q4
$467K Buy
5,545
+585
+12% +$47.2K 0.01% 1075
2019
Q3
$371K Sell
4,960
-335
-6% -$26.8K 0.01% 1199
2019
Q2
$335K Sell
5,295
-730
-12% -$37K 0.01% 1228
2019
Q1
$290K Sell
6,025
-175
-3% -$8.42K 0.01% 1207
2018
Q4
$208K Buy
6,200
+165
+3% +$6.03K 0.01% 1190
2018
Q3
$316K Buy
+6,035
New +$240K 0.01% 1200

Other funds holding NVCR

Private Advisor Group's NVCR Position: Q2 2023 in Review

Private Advisor Group sold out of NovoCure (NVCR) in Q2 2023, closing a stake of 3,912 shares — an estimated $235K sold.

Private Advisor Group first reported a position in NVCR in Q3 2018 and held it in 18 quarters. The position peaked at $1.28M in Q2 2021. 267 funds tracked by Wall St. Rank hold NVCR as of Q2 2023.

  • Private Advisor Group reported no remaining NovoCure position as of Q2 2023 after selling out during the quarter.
  • Private Advisor Group sold 3,912 NovoCure shares in Q2 2023, an estimated $235K.
  • Private Advisor Group first reported a position in NovoCure in Q3 2018 and held it in 18 quarters.
  • Private Advisor Group's NovoCure position peaked at $1.28M in Q2 2021.
  • 267 funds tracked by Wall St. Rank held NovoCure as of Q2 2023.

Based on Private Advisor Group's 13F filing for Q2 2023, filed 10 Aug 2023.